These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24919924)

  • 1. Formulation of inhalable lipid-based salbutamol sulfate microparticles by spray drying technique.
    Daman Z; Gilani K; Rouholamini Najafabadi A; Eftekhari HR; Barghi MA
    Daru; 2014 Jun; 22(1):50. PubMed ID: 24919924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aerosolization characteristics of dry powder inhaler formulations for the excipient enhanced growth (EEG) application: effect of spray drying process conditions on aerosol performance.
    Son YJ; Worth Longest P; Hindle M
    Int J Pharm; 2013 Feb; 443(1-2):137-45. PubMed ID: 23313343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agglomerated novel spray-dried lactose-leucine tailored as a carrier to enhance the aerosolization performance of salbutamol sulfate from DPI formulations.
    Molina C; Kaialy W; Chen Q; Commandeur D; Nokhodchi A
    Drug Deliv Transl Res; 2018 Dec; 8(6):1769-1780. PubMed ID: 29260462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
    Zeng XM; MacRitchie HB; Marriott C; Martin GP
    Int J Pharm; 2007 Mar; 333(1-2):45-55. PubMed ID: 17064863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-spraying of carriers (mannitol-lactose) as a method to improve aerosolization performance of salbutamol sulfate dry powder inhaler.
    Ferdynand MS; Nokhodchi A
    Drug Deliv Transl Res; 2020 Oct; 10(5):1418-1427. PubMed ID: 31933129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved aerosolization performance of salbutamol sulfate formulated with lactose crystallized from binary mixtures of ethanol-acetone.
    Kaialy W; Ticehurst MD; Murphy J; Nokhodchi A
    J Pharm Sci; 2011 Jul; 100(7):2665-84. PubMed ID: 21268026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elucidating the Effect of Fine Lactose Ratio on the Rheological Properties and Aerodynamic Behavior of Dry Powder for Inhalation.
    Sun Y; Qin L; Li J; Su J; Song R; Zhang X; Guan J; Mao S
    AAPS J; 2021 Apr; 23(3):55. PubMed ID: 33856568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Granulated Lactose as a Carrier for Dry Powder Inhaler Formulations 2: Effect of Drugs and Drug Loading.
    Du P; Du J; Smyth HDC
    J Pharm Sci; 2017 Jan; 106(1):366-376. PubMed ID: 27939234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering of levodopa inhalable microparticles in combination with leucine and dipalmitoylphosphatidylcholine by spray drying technique.
    Bahrainian S; Mirmoeini MS; Gilani Z; Gilani K
    Eur J Pharm Sci; 2021 Dec; 167():106008. PubMed ID: 34530077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the effect of the size of polycaprolactone microspheres for the dispersion of salbutamol sulfate from dry powder inhaler formulations.
    Tuli RA; George GA; Dargaville TR; Islam N
    Pharm Res; 2012 Sep; 29(9):2445-55. PubMed ID: 22584947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation development and in vivo evaluation of a new dry powder formulation of albuterol sulphate in beagle dogs.
    Kuehl PJ; Barrett EG; McDonald JD; Rudolph K; Vodak D; Dobry D; Lyon D
    Pharm Res; 2010 May; 27(5):894-904. PubMed ID: 20232119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of loaded carrier mass and formulation mass on aerosolization efficiency in dry powder inhaler devices.
    Ooi J; Gill C; Young PM; Traini D
    Curr Drug Deliv; 2015; 12(1):40-6. PubMed ID: 25146438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Dry Powder Inhaler Carrier Targeted Design: A Comparative Case Study of Diverse Anomeric Compositions and Physical Properties of Lactose.
    Pinto JT; Zellnitz S; Guidi T; Roblegg E; Paudel A
    Mol Pharm; 2018 Jul; 15(7):2827-2839. PubMed ID: 29856921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of L-leucine in reducing the moisture-induced deterioration of spray-dried salbutamol sulfate power for inhalation.
    Li L; Leung SSY; Gengenbach T; Yu J; Gao GF; Tang P; Zhou QT; Chan HK
    Int J Pharm; 2017 Sep; 530(1-2):30-39. PubMed ID: 28709940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Freeze-dried mannitol for superior pulmonary drug delivery via dry powder inhaler.
    Kaialy W; Nokhodchi A
    Pharm Res; 2013 Feb; 30(2):458-77. PubMed ID: 23070603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation and deposition studies of recrystallised lactose from binary mixtures of ethanol/butanol for improved drug delivery from dry powder inhalers.
    Kaialy W; Martin GP; Ticehurst MD; Royall P; Mohammad MA; Murphy J; Nokhodchi A
    AAPS J; 2011 Mar; 13(1):30-43. PubMed ID: 21057906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of liposomal salbutamol sulfate dry powder inhaler formulation.
    Huang WH; Yang ZJ; Wu H; Wong YF; Zhao ZZ; Liu L
    Biol Pharm Bull; 2010; 33(3):512-7. PubMed ID: 20190418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of Formulation and Device Factors Determine the In Vitro Performance of Salbutamol Sulphate Dry Powders for Inhalation.
    Muddle J; Murnane D; Parisini I; Brown M; Page C; Forbes B
    J Pharm Sci; 2015 Nov; 104(11):3861-3869. PubMed ID: 26220184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the Different Effects of Inhaler Design on the Aerosol Performance of Drug-Only and Carrier-Based DPI Formulations. Part 1: Grid Structure.
    Leung CMS; Tong Z; Zhou QT; Chan JGY; Tang P; Sun S; Yang R; Chan HK
    AAPS J; 2016 Sep; 18(5):1159-1167. PubMed ID: 27161214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of storage humidity on the in vitro inhalation properties of salbutamol sulfate dry powder with surface covered lactose carrier.
    Iida K; Hayakawa Y; Okamoto H; Danjo K; Luenberger H
    Chem Pharm Bull (Tokyo); 2004 Apr; 52(4):444-6. PubMed ID: 15056961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.